Axovant Sciences Ltd. (AXON ) Earnings
|
Expand Research on AXON
| Next EPS Date | 8/11/26 | EPS Growth Rate | -14.6% |
|---|---|---|---|
| Average EPS % Beat Rate | +14.3% | Revenue Growth Rate | +31.0% |
| Average % Move 1-Wk after EPS | +4.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/26  |
Q226 | N/A | $1.81 | N/A | N/A | $876.46M | N/A | N/A | N/A | ||
| 5/6/26 | Q126 | $1.61 | $1.60 | +$0.01 | $807.35M | $778.45M | N/A |  | | Details | |
| 2/24/26 | Q425 | $2.15 | $1.60 | +$0.55 | $797M | $755.55M | N/A | | | Details | |
| 11/4/25 | Q325 | $1.17 | $1.52 | -$0.35 | $711M | $704.84M | = | | | Details | |
| 8/4/25 | Q225 | $2.12 | $1.46 | +$0.66 | $669M | $640.3M | = | | | Details | |
| 5/7/25 | Q125 | $1.41 | $1.30 | +$0.11 | $604M | $585.67M | = | | | Details | |
| 2/25/25 | Q424 | $2.08 | $1.40 | +$0.68 | $575M | $566.8M | = | | | Details | |
| 11/7/24 | Q324 | $1.45 | $1.19 | +$0.26 | $544.27M | $524.47M | = | | | Details |
